# INQOVI
> **NDA212576** · New Drug Application · Sponsor: TAIHO ONCOLOGY · Approved 2020-07-07
## Drug
- **FDA Application Number:** NDA212576
- **Application type:** New Drug Application
- **Brand name:** INQOVI
- **Generic name:** CEDAZURIDINE AND DECITABINE
- **Active ingredients:** CEDAZURIDINE; DECITABINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TAIHO ONCOLOGY
- **Manufacturer:** Taiho Pharmaceutical Co., Ltd.
- **First approval:** 2020-07-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212576)
---
*AI Analytics · CC0 1.0*